ECSP056057A - Compuestos de benzo[1,2,5]tiadiazole - Google Patents

Compuestos de benzo[1,2,5]tiadiazole

Info

Publication number
ECSP056057A
ECSP056057A EC2005006057A ECSP056057A ECSP056057A EC SP056057 A ECSP056057 A EC SP056057A EC 2005006057 A EC2005006057 A EC 2005006057A EC SP056057 A ECSP056057 A EC SP056057A EC SP056057 A ECSP056057 A EC SP056057A
Authority
EC
Ecuador
Prior art keywords
tiadiazole
benzo
benzo compounds
compounds
cck2
Prior art date
Application number
EC2005006057A
Other languages
English (en)
Inventor
Brett D Allison
Laura C Mcatee
Victor K Phuong
Michael H Rabinowitz
Nigel P Shankley
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP056057A publication Critical patent/ECSP056057A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ciertos compuestos de amidofenil-sufanilamino-benzo[1,2,5]tiadiazole son moduladores CCK2 útiles en el tratamiento de enfermedades mediadas por CCK2.
EC2005006057A 2003-03-28 2005-09-28 Compuestos de benzo[1,2,5]tiadiazole ECSP056057A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45863803P 2003-03-28 2003-03-28

Publications (1)

Publication Number Publication Date
ECSP056057A true ECSP056057A (es) 2006-01-27

Family

ID=34115280

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006057A ECSP056057A (es) 2003-03-28 2005-09-28 Compuestos de benzo[1,2,5]tiadiazole

Country Status (20)

Country Link
US (2) US7241759B2 (es)
EP (1) EP1675837A2 (es)
JP (1) JP2006528241A (es)
KR (1) KR20050119666A (es)
CN (1) CN1829704A (es)
AU (1) AU2004261547A1 (es)
BR (1) BRPI0408899A (es)
CA (1) CA2520546A1 (es)
CO (1) CO5700819A2 (es)
CR (1) CR8009A (es)
EC (1) ECSP056057A (es)
IS (1) IS8042A (es)
MX (1) MXPA05010484A (es)
NO (1) NO20055002L (es)
NZ (1) NZ542491A (es)
RS (1) RS20050733A (es)
RU (1) RU2005133206A (es)
UA (1) UA82872C2 (es)
WO (1) WO2005012275A2 (es)
ZA (1) ZA200508732B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
KR20070057252A (ko) 2004-09-24 2007-06-04 얀센 파마슈티카 엔.브이. 설폰아미드 화합물
US7599588B2 (en) * 2005-11-22 2009-10-06 Vascular Imaging Corporation Optical imaging probe connector
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
WO2008124518A1 (en) * 2007-04-03 2008-10-16 Janssen Pharmaceutica N.V. Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
EP2053052A1 (en) * 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
CR20170071A (es) 2009-06-29 2017-03-28 Agios Pharmaceuticals Inc Compuestos terapeuticos y composiciones
RU2532492C1 (ru) * 2013-01-28 2014-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ эндоскопического лечения гастродуоденальных язв
KR102254957B1 (ko) 2013-11-22 2021-05-25 씨엘 바이오사이언시즈 엘엘씨 골다공증 치료 및 예방을 위한 가스트린 길항제(ｅｇ ｙｆ476, 네타제피드)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
CA2274669C (en) * 1996-12-10 2006-11-14 Zeria Pharmaceutical Co., Ltd. 1,5-benzodiazepine derivatives
BR0011571A (pt) * 1999-06-24 2002-03-05 Smithkline Beecham Corp Antagonistas do receptor de limpeza de macrófago
GB0028702D0 (en) * 2000-11-24 2001-01-10 Novartis Ag Organic compounds
EP1385841A4 (en) 2001-05-07 2005-03-02 Smithkline Beecham Corp SULPHONAMIDES
ITTO20020674A1 (it) 2002-07-26 2004-01-26 Rotta Research Lab Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico

Also Published As

Publication number Publication date
UA82872C2 (en) 2008-05-26
CN1829704A (zh) 2006-09-06
US20070276016A1 (en) 2007-11-29
NZ542491A (en) 2009-04-30
AU2004261547A1 (en) 2005-02-10
US7241759B2 (en) 2007-07-10
NO20055002L (no) 2005-12-14
CR8009A (es) 2008-09-10
BRPI0408899A (pt) 2006-04-18
ZA200508732B (en) 2007-04-25
NO20055002D0 (no) 2005-10-27
WO2005012275A2 (en) 2005-02-10
RU2005133206A (ru) 2006-05-10
CO5700819A2 (es) 2006-11-30
KR20050119666A (ko) 2005-12-21
WO2005012275A3 (en) 2006-05-11
JP2006528241A (ja) 2006-12-14
US7550492B2 (en) 2009-06-23
EP1675837A2 (en) 2006-07-05
RS20050733A (sr) 2007-06-04
CA2520546A1 (en) 2005-02-10
IS8042A (is) 2005-09-23
MXPA05010484A (es) 2006-03-10
US20040224983A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
ECSP066355A (es) Compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de la colecistocinina 2
SV2005001973A (es) Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)
NI200600094A (es) Compuesto heterociclicos fusionados
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
BRPI0414598A (pt) indóis substituìdos
TW200509892A (en) Novel aminobenzophenone compounds
ECSP066549A (es) Compuestos de pirazolilo e imidazolilo bicíclicos y usos de los mismos
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
ECSP056057A (es) Compuestos de benzo[1,2,5]tiadiazole
DE50310579D1 (de) Furancarboxamide
ATE417856T1 (de) Motilidverbindungen
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
DE50312430D1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
ATE460938T1 (de) Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
ATE403660T1 (de) Benzo 4,5 thieno 3,2-b pyran-2-on enthaltende duftstoffzusammensetzungen
UA85563C2 (ru) Конденсированные гетероциклические соединения
NO20060361L (no) Nye cytotoxiske depsipeptider
EP1436279B8 (en) Chemical compounds
AU2003266093A1 (en) Cyclooct-(en-)yl derivatives for use as fragrances
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
BRPI0515383A (pt) n-etil hidroxietilamina útil no tratamento de condições do snc
SE0301798D0 (sv) New use IV